VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Ruff on Aflibercept in Elderly Patients With CRC

Paul Ruff, MD
Published: Wednesday, Oct 09, 2013

Paul Ruff, MD, director of Medical Oncology at the University of Witwatersrand, Johannesburg, South Africa, discusses treating elderly patients with colorectal cancer with aflibercept.

Ruff says physicians can use aflibercept to treat elderly patients with colorectal cancer as long as they are careful. Some side effects, such as dehydration, seem to be more severe in patients with colorectal cancer who are over the age of 65, Ruff says.

Ruff believes that most oncologists are aware of how to manage side effects from chemotherapy and anti-angiogenic agents. With good care management and proper awareness of its side effects, aflibercept can be used as a useful agent in the management of advanced colorectal cancer.

Paul Ruff, MD, director of Medical Oncology at the University of Witwatersrand, Johannesburg, South Africa, discusses treating elderly patients with colorectal cancer with aflibercept.

Ruff says physicians can use aflibercept to treat elderly patients with colorectal cancer as long as they are careful. Some side effects, such as dehydration, seem to be more severe in patients with colorectal cancer who are over the age of 65, Ruff says.

Ruff believes that most oncologists are aware of how to manage side effects from chemotherapy and anti-angiogenic agents. With good care management and proper awareness of its side effects, aflibercept can be used as a useful agent in the management of advanced colorectal cancer.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x